Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of the Ocoxin®-Viusid® Nutritional Supplement on the Quality of Life of Patients With Metastatic Colorectal Adenocarcinoma. Phase II

NCT03559543 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT03559543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of the Ocoxin®-Viusid® Nutritional Supplement on the Quality of Life of Patients With Metastatic Colorectal Adenocarcinoma. Phase II
Lead sponsor
Catalysis SL
Phase
Phase 2
Overall status
Completed
Start date
October 25, 2018
Completion date
January 15, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colonic diseases, colorectal neoplasm, digestive system disease, digestive system neoplasm, gastrointestinal disease, gastrointestinal neoplasms, intestinal disease, intestinal neoplasms, rectal diseases